Earth Science Tech (ETST) Other Accumulated Expenses (2022 - 2023)
Earth Science Tech's (ETST) quarterly Other Accumulated Expenses came in at $33525.0 in Q4 2023, up 708.61% quarter-over-quarter from $4146.0 in Q1 2023.
Powered by 
Analysis
Earth Science Tech (ETST) Other Accumulated Expenses (2022 - 2023) Analysis & Trends
Earth Science Tech (ETST) has reported Other Accumulated Expenses for 2 consecutive years, with $33525.0 the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Other Accumulated Expenses changed N/A year-over-year to $33525.0; the trailing twelve-month figure through Dec 2023 stood at $33525.0 (changed N/A YoY), and the FY2023 full-year result was $4146.0, up 118.79% from the prior year.
- Other Accumulated Expenses rose to $33525.0 in Q4 2023 per ETST's latest filing, from $4146.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $33525.0 in Q4 2023 and bottomed at $1895.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 33,525.00 |
| Mar 31, 2023 | 4,146.00 |
| Mar 31, 2022 | 1,895.00 |